coinix GmbH & Co. KGaA has invested €100,000 in the DeFi project Fungi through a SAFT, valuing it at €7.5 million.

Information on the Target

Fungi is a fully automated decentralized finance (DeFi) agent specializing in optimizing yield returns using stablecoins. Users benefit from a smart, non-custodial system that autonomously reallocates invested capital daily among various decentralized protocols. The agent takes into account a multitude of relevant parameters, such as expected returns, gas fees, slippage, liquidity, and protocol risks. Currently managing approximately $500,000 in assets and with over $100 million in trading volume executed, Fungi demonstrates strong market traction. The solution is live on the Base blockchain and is continuously being developed to incorporate additional blockchains and expand yield generation capabilities.

Fungi operates on an individualized basis for each user, providing a unique instance of the agent that monitors deposited stablecoins around the clock and automatically reacts to favorable yield opportunities. When a transition between supported protocols is beneficial, capital is reallocated; otherwise, funds remain securely in place. The decision-making process involves various factors, including base and bonus interest rates, time-limited rewards, transaction costs, liquidity, and the inherent risks of each protocol.

Industry Overview in the Target’s Specific Country

The DeFi sector has witnessed exponential growth recently, driven by the increasing adoption of blockchain technology and decentralized applications. In Germany, the regulatory framework is gradually adapting to this n